2020
DOI: 10.1097/cm9.0000000000001040
|View full text |Cite
|
Sign up to set email alerts
|

Coexistence of acne inversa with psoriasis and Dowling-Degos disease harboring impaired PSENEN-Notch signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 5 publications
(8 reference statements)
0
3
0
Order By: Relevance
“…Although rare, DDD should be considered in the differential diagnosis of patients presenting with 3,5,7,9,10,12,14,17,18,[28][29][30][31][32][33][34][35][36][37][38] 28,31,42 3 66 (64-68) 0 -EIC 11,12 2 54 (49-58) 50 -Fingernail dystrophy 1, 23 2 48 (36-59) 100 -Amelanocytic malignant melanoma 43 1 5 1 0 -Darier disease 44 1 6 2 0 -Eczematous plaques 8 1 9 100 POFTU1 (n = 1) Ichthyosis vulgaris 4 1 2 5 0 -Keratocanthomas*, 33 1 ---Leukoderma 22 1 26 100 -Palmoplantar hyperhydrosis 22 1 26 100 -Palmoplantar keratodema 22 1 26 100 -Pemphigus vulgaris 11 1 5 8 0 -Pilonidal sinus*, 45 1 ---Psoriasis 6 1 53 100 Recurrent medial thigh abscesses 22 1 27 100 -*Age and gender not reported in all cases.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although rare, DDD should be considered in the differential diagnosis of patients presenting with 3,5,7,9,10,12,14,17,18,[28][29][30][31][32][33][34][35][36][37][38] 28,31,42 3 66 (64-68) 0 -EIC 11,12 2 54 (49-58) 50 -Fingernail dystrophy 1, 23 2 48 (36-59) 100 -Amelanocytic malignant melanoma 43 1 5 1 0 -Darier disease 44 1 6 2 0 -Eczematous plaques 8 1 9 100 POFTU1 (n = 1) Ichthyosis vulgaris 4 1 2 5 0 -Keratocanthomas*, 33 1 ---Leukoderma 22 1 26 100 -Palmoplantar hyperhydrosis 22 1 26 100 -Palmoplantar keratodema 22 1 26 100 -Pemphigus vulgaris 11 1 5 8 0 -Pilonidal sinus*, 45 1 ---Psoriasis 6 1 53 100 Recurrent medial thigh abscesses 22 1 27 100 -*Age and gender not reported in all cases.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, mutations in keratin 5 (KRT5), keratin 14, protein O-fucosyltransferase 1 (POFUT1), and presenilin enhancer protein 2 gene (PSENEN) have been observed in affected patients. 2,[5][6][7][8][9][10] The concurrent presentation of DDD and hidradenitis suppurativa (HS) has been well described, with multiple studies demonstrating underlying genetic mutations involved in similar pathways, suggesting these conditions may be etiologically related. Other dermatologic conditions have been less commonly reported in conjunction with DDD, with unknown etiologic associations.…”
Section: Introductionmentioning
confidence: 99%
“…60 In 2 separate case studies of HS and Dowling-Degos disease, a rare autosomal dominant disease characterized by reticulate hyperpigmentation and dark brown papules, mutations in PSENEN were discovered by Sanger sequencing, while another case study reported a mutation in POFUT1. [62][63][64] Marzano et al 27 utilized WES to identify mutations in 10 syndromic HS patients, rather than the targeted panels used in the case studies of the familial and sporadic case studies, and yielded a variety of genes within and outside of the GSC. Genetic variants were discovered in MEVF, PSTPIP1, NLRC4, WDR1, NOD2, OTULIN, NCSTN, and GJB2, which may be attributed to identification by WES, the presence of additional inflammatory disorders, or the polygenic nature of HS.…”
Section: Syndromic Hsmentioning
confidence: 99%
“…Furthermore, several reports suggest that PSENEN mutations are involved in the occurrence and development of hidradenitis suppurativa (HS) and Dowling-Degos disease (DDD). Specifically, Xiao et al (2020) found that PSENEN mutations in patients with HS predispose them to DDD by disrupting Notch signaling. Li et al (2018) observed that the location of PSENEN mutations in patients with HS all occurred in transmembrane regions that are expected to disrupt membrane function.…”
Section: Introductionmentioning
confidence: 99%